Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For HLE.SW
Valuation Bad
0%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Bad
0%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio 1.95 1.40 1.37
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -23.16 0.74 0.97
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value -0.86 26.04 26.27
Cash 14.99 10.71 9.31
Capex 96.21 -0.06 -1.51
Free Cash Flow 549.65 3.04 -0.47
Revenue 4.35 18.20 17.44
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin -1.94 0.25 0.26
Operating Margin -31.11 0.04 0.06
ROA -49.31 < 0.005 < 0.005
ROE -45.93 0.01 0.02
ROIC -46.07 < 0.005 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of HLE.SW is permitted for members.
5 Growth
The "Growth Entry" for the Focus of HLE.SW is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of HLE.SW is permitted for members.